tiprankstipranks
Advertisement
Advertisement

PASG Stock Latest News

Guggenheim downgrades Passage Bio to Neutral, terminates coverage
The FlyGuggenheim downgrades Passage Bio to Neutral, terminates coverage
10d ago
PASG
Passage Bio downgraded to Neutral from Buy at Guggenheim
PremiumThe Fly
Passage Bio downgraded to Neutral from Buy at Guggenheim
10d ago
PASG
Passage Bio Ends Key Collaborations and Office Lease
PremiumCompany Announcements
Passage Bio Ends Key Collaborations and Office Lease
24d ago
8K
PASG
Passage Bio Shareholders Approve Directors and Executive Pay
PremiumCompany Announcements
Passage Bio Shareholders Approve Directors and Executive Pay
25d ago
8K
PASG
Is PASG a Buy, Before Earnings?
PremiumPre-Earnings
Is PASG a Buy, Before Earnings?
1M ago
PASG
Passage Bio Announces Major Workforce Reduction and Restructuring
PremiumCompany AnnouncementsPassage Bio Announces Major Workforce Reduction and Restructuring
2M ago
8K
PASG
Wedbush downgrades Passage Bio to Neutral on regulatory uncertainties
Premium
The Fly
Wedbush downgrades Passage Bio to Neutral on regulatory uncertainties
2M ago
PASG
Passage Bio downgraded to Hold from Buy at TD Cowen
Premium
The Fly
Passage Bio downgraded to Hold from Buy at TD Cowen
2M ago
PASG
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
PremiumThe Fly
Intel upgraded, Reddit initiated: Wall Street’s top analyst calls
2M ago
CL
MHK
Passage Bio price target lowered to $15 from $30 at Oppenheimer
PremiumThe Fly
Passage Bio price target lowered to $15 from $30 at Oppenheimer
2M ago
PASG
Buy Rating Reaffirmed on Encouraging upliFT-D Biomarker Data and Solid Cash Runway Supporting Expanded FTD-GRN Trial
PremiumRatings
Buy Rating Reaffirmed on Encouraging upliFT-D Biomarker Data and Solid Cash Runway Supporting Expanded FTD-GRN Trial
2M ago
PASG
Passage Bio downgraded to Neutral from Outperform at Wedbush
PremiumThe Fly
Passage Bio downgraded to Neutral from Outperform at Wedbush
2M ago
PASG
Passage Bio: Regulatory Setback and Resource Constraints Drive Cautious Hold Amid Long-Term Optionality
PremiumRatingsPassage Bio: Regulatory Setback and Resource Constraints Drive Cautious Hold Amid Long-Term Optionality
2M ago
PASG
Passage Bio downgraded to Neutral from Buy at Chardan
Premium
The Fly
Passage Bio downgraded to Neutral from Buy at Chardan
2M ago
PASG
Passage Bio downgraded to Neutral from Buy at Lucid Capital
Premium
The Fly
Passage Bio downgraded to Neutral from Buy at Lucid Capital
2M ago
PASG
Passage Bio Announces PBFT02 Data and Strategic Review
PremiumCompany Announcements
Passage Bio Announces PBFT02 Data and Strategic Review
2M ago
8K
PASG
Passage Bio reports updated interim data from upliFT-D trial
PremiumThe Fly
Passage Bio reports updated interim data from upliFT-D trial
2M ago
PASG
Passage Bio initiated with an Outperform at Oppenheimer
PremiumThe Fly
Passage Bio initiated with an Outperform at Oppenheimer
3M ago
PASG
QURE
Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway
PremiumCompany Announcements
Passage Bio Ends Hopewell Lab Lease, Extends Cash Runway
3M ago
8K
PASG
Passage Bio price target lowered to $23 from $67 at Canaccord
PremiumThe FlyPassage Bio price target lowered to $23 from $67 at Canaccord
4M ago
PASG
Passage Bio Reports 2025 Results, Advances FTD Program
Premium
Company Announcements
Passage Bio Reports 2025 Results, Advances FTD Program
4M ago
8K
PASG
Passage Bio reports Q4 EPS ($4.09), consensus ($2.80)
Premium
The Fly
Passage Bio reports Q4 EPS ($4.09), consensus ($2.80)
4M ago
PASG

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >